The forecasted import of penicillins to the US shows a significant downward trend from 2024 to 2028, decreasing from 532.87 to 151.59 thousand kilograms. The year-on-year percentage variations illustrate a steady decline: -18.45% from 2024 to 2025, -22.16% from 2025 to 2026, -27.89% from 2026 to 2027, and -37.85% from 2027 to 2028. This results in a compound annual growth rate (CAGR) of approximately -27.61% over the five-year period.
Future trends to watch for include:
- Impact of potential policy changes on pharmaceutical imports.
- Technological advancements in domestic production.
- Global supply chain dynamics and their influence on US imports.
